netFormulary North of Tyne and Gateshead Area Prescribing Committee NHS
Formulary  
 Search
 Formulary Chapter 3: Respiratory system - Full Section
Notes:

Choice of inhaler device should be dependent on patient ability to use. Devices should be chosen based on availability for the type of drug to be prescribed and the patient’s ability to use it.

*Important*


Note: All new patients should be started on the updated formulary choices as per local/national guidelines.

When inhalers are removed from the formulary, existing, stable, patients should continue to receive the non-formulary device. Treatment should not be changed unless a full face to face review has been conducted.

 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
03.01 Bronchodilators (0,0)
Asthma (0,0)
Chronic obstructive pulmonary disease (0,0)
Croup (0,0)
03.01.01 Adrenoceptor agonists (0,0)
03.01.01.01 Selective Beta2 agonists (0,0)
Short-acting beta2 agonists (2,0)
Long-acting beta2 agonists (2,0)
03.01.01.02 Other adrenoceptor agonists (1,0)
03.01.02 Antimuscarinic bronchodilators (5,0)
03.01.03 Theophylline (2,0)
03.01.04 Compound bronchodilator preparations (4,0)
03.01.05 Peak flow meters, inhaler devices and nebulisers (0,0)
Peak flow meters (0,0)
Drug delivery devices (2,0)
Nebulisers (0,0)
Nebuliser Diluent (0,0)
03.02 Corticosteroids (8,0)
03.03 Cromoglicate, related therapy and leukotriene receptor antagonists (0,0)
03.03.01 Cromoglicate and related therapy (0,0)
Related therapy (0,0)
03.03.02 Leukotriene receptor antagonists (1,0)
03.03.03 Phosphodiesterase type-4 inhibitors (1,0)
03.04 Antihistamines, hyposensitisation, and allergic emergencies (0,0)
03.04.01 Antihistamines (0,0)
Non-sedating antihistamines (4,0)
Sedating antihistamines (4,0)
03.04.02 Allergen Immunotherapy (4,0)
Mepolizumab & Omalizumab (3,0)
03.04.03 Allergic emergencies (0,0)
Anaphylaxis (2,0)
Angioedema (5,0)
Intramuscular adrenaline (epinephrine) (0,0)
Intravenous adrenaline (epinephrine) (0,0)
Self-administration of adrenaline (epinephrine) (0,0)
03.05 Respiratory stimulants and pulmonary surfactants (0,0)
03.05.01 Respiratory stimulants (3,0)
03.05.02 Pulmonary surfactants (1,0)
03.06 Oxygen (0,0)
Long-term oxygen therapy (0,0)
Short burst oxygen therpary (0,0)
Ambulatory oxygen therapy (0,0)
Oxygen therapy equipment (0,0)
Arrangements for supplying oxygen (0,0)
03.07 Mucolytics (3,0)
Dornase alfa (1,0)
Hypertonic Sodium Chloride (1,0)
Mannitol (2,0)
03.08 Aromatic inhalations (0,0)
03.09 Cough preparations (0,0)
03.09.01 Cough suppressants (2,0)
Palliative care (0,0)
03.09.02 Expectorant and demulcent cough preparations (1,0)
03.10 Systemic nasal decongestants (1,0)
03.11 Antifibrotics (2,0)
netFormulary